| Date Filed | Type | Description |
| 08/22/2023 |
4
| GRAHAM RICHARD A (SVP, RESEARCH & DEVELOPMENT) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 10,461 shares
@ $9.7, valued at
$101.5k
|
|
| 08/15/2023 |
4
| GRAHAM RICHARD A (SVP, RESEARCH & DEVELOPMENT) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Sold 2,322 shares
@ $9.99, valued at
$23.2k
|
|
| 08/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
4
| GRAHAM RICHARD A (SVP, RESEARCH & DEVELOPMENT) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Sold 2,322 shares
@ $10.69, valued at
$24.8k
|
|
| 05/23/2023 |
4
| GRAHAM RICHARD A (SVP, RESEARCH & DEVELOPMENT) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 10,460 shares
@ $11.21, valued at
$117.3k
|
|
| 05/17/2023 |
4
| GRAHAM RICHARD A (SVP, RESEARCH & DEVELOPMENT) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Sold 2,322 shares
@ $11.26, valued at
$26.1k
|
|
| 05/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/16/2023 |
4
| GRAHAM RICHARD A (SVP, RESEARCH & DEVELOPMENT) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Sold 2,323 shares
@ $10.32, valued at
$24k
|
|
| 03/08/2023 |
4
| GRAHAM RICHARD A (SVP, RESEARCH & DEVELOPMENT) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Sold 2,323 shares
@ $10.05, valued at
$23.3k
|
|
| 03/03/2023 |
4
| GRAHAM RICHARD A (SVP, RESEARCH & DEVELOPMENT) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 75,000 shares
@ $0 |
|
| 02/22/2023 |
4
| GRAHAM RICHARD A (SVP, RESEARCH & DEVELOPMENT) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 12,057 shares
@ $10.44, valued at
$125.9k
|
|
| 12/05/2022 |
4
| GRAHAM RICHARD A (SVP, RESEARCH & DEVELOPMENT) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Sold 2,084 shares
@ $10.73, valued at
$22.4k
|
|
| 11/22/2022 |
4
| GRAHAM RICHARD A (SVP, RESEARCH & DEVELOPMENT) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 27,350 shares
@ $10.85, valued at
$296.7k
|
|
| 11/17/2022 |
4
| GRAHAM RICHARD A (SVP, RESEARCH & DEVELOPMENT) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 2,800 shares
@ $11.2, valued at
$31.4k
|
|
| 08/23/2022 |
4
| GRAHAM RICHARD A (SVP, DEVELOPMENT) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 18,991 shares
@ $9.34, valued at
$177.4k
|
|
| 08/18/2022 |
4
| GRAHAM RICHARD A (SVP, DEVELOPMENT) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Sold 4,906 shares
@ $9.7105, valued at
$47.6k
|
|
| 05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2021 |
4
| GRAHAM RICHARD A (SVP, DEVELOPMENT) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 4,263 shares
@ $8.36, valued at
$35.6k
|
|
| 08/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2020 |
4
| GRAHAM RICHARD A (SVP, Development) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Sold 7,500 shares
@ $19.4744, valued at
$146.1k
|
|
| 11/24/2020 |
4
| GRAHAM RICHARD A (SVP, Development) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 3,876 shares
@ $17.21, valued at
$66.7k
|
|
| 09/03/2020 |
4
| GRAHAM RICHARD A (SVP, Development) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 27,500 shares
@ $0 |
|
| 08/24/2020 |
4
| GRAHAM RICHARD A (SVP, Development) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 6,598 shares
@ $18.22, valued at
$120.2k
|
|
| 08/10/2020 |
3
| GRAHAM RICHARD A (SVP, Development) has filed a Form 3 on Theravance Biopharma, Inc. |